Regulatory
IDEXX's equine topical anti-inflammatory gains FDA approval
October 1st 2004IDEXX Laboratories Inc. received approval from the U.S. Food and Drug Administration (FDA) to market and sell Surpass? (1% diclofenac sodium) Topical Anti-Inflammatory Cream, a new treatment for horses with pain and lameness due to osteo-arthritis.
FDA gives nod to Pfizer's oral cephalosporin for canine skin infections
October 1st 2004NEW YORK - Pfizer Animal Health received approval from the Food and Drug Administration (FDA) for Simplecef? (cefpodoxime proxetil) tablets, the only oral cephalosporin approved to treat canine skin infections (wounds and abscesses) with the ease of once-daily dosing.
IDEXX's equine topical anti-inflammatory gains FDA approval
July 1st 2004WESTBROOK, MAINE-IDEXX Laboratories, Inc., received approval from the U.S. Food and Drug Administration (FDA) to market and sell Surpass? (1% diclofenac sodium) Topical Anti-Inflammatory Cream, a new treatment for horses with pain and lameness due to osteoarthritis.
Supreme Court ruling bares history of FDA action
July 1st 2004Washington-As the U.S. Food and Drug Administration's (FDA) labors to restrict compounded drugs for nonfood animals, its efforts are preceded by a 2002 Supreme Court case in which justices criticized the agency for restricting pharmacists' free speech rights.
USDA ruling may call DVMs to action in BSE surveillance
February 1st 2004Washington-In the wake of the country's first case of mad cow disease, the United States Department of Agriculture's (USDA) ruling to ban all non-ambulatory, disabled livestock from being slaughtered may mean that the government will rely on veterinarians and producers to get access to test animals at highest risk for mad cow disease.
Iowa regulators back off pet food industry; FDAsteps in
January 1st 2004Des Moines-Food and Drug Administration (FDA) officials eased an Iowa crackdown on pet foods containing glucosamine and chondroitin last month with its resolution to review animal supplements, stripping the issue from the state's jurisdiction.
FDA OKs injectable form of non-steroidal anti-inflammatory
January 1st 2004The U.S. Food and Drug Administration granted marketing approval for Metacam Injectable, a non-steroidal anti-inflammatory drug (NSAID), made by Boehringer Ingelheim Vetmedica (BI) and being distributed by Merial. Coupled with Metacam Oral Suspension, the injectable offers an effective source for relief of pain associate with canine osteoarthritis, the company says.
FDA draft risk assessment says clones likely safe, but cites animal health concerns
December 1st 2003Rockville, Md.-In the wake of a Food and Drug Administration (FDA) draft risk assessment on the safety of animal cloning, the FDA's Veterinary Medical Advisory Committee (VMAC) agreed that products generated from clones would likely be safe to eat but some panel members expressed concern on the risks to animal welfare.